Latest filing published 06 Jan 2023 for Selecta Biosciences INC, €6,859.
Filing timeline
BuySaleInsider track record
Lloyd P. Johnston: trading record in brief
Lloyd P. Johnston (senior executive) discloses dealings in Cartesian Therapeutics, Inc. to SEC (Form 4). Between 23 January 2017 and 5 January 2023, the trades on record add up to 28 filings.
No open-market purchase appears, only 15 sales worth €1.0M. The rest of the record consists of 5 share grants and 8 option exercises. Since January 2023: no purchases and 4 sales on the market.
Most recently, on 6 January 2023, the filings show an open-market sale worth €21 in Cartesian Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lloyd P. Johnston
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,381 shares@ US$1.133716.1% of flowCommon StockSEC:0001453687-23-000034:0
- 100,000 shares0Common StockSEC:0001453687-23-000019:0
- 3,416 shares@ US$3.085922.0% of flowCommon StockSEC:0001453687-22-000032:0
- 72,000 shares0Common StockSEC:0001453687-22-000019:0
- 4,370 shares@ US$2.986927.2% of flowCommon StockSEC:0001453687-21-000184:0
- 13,750 shares0Common StockSEC:0001453687-21-000174:0
- 3,892 shares@ US$4.3934.7% of flowCommon StockSEC:0001453687-21-000142:0
- 13,750 shares0Common StockSEC:0001453687-21-000133:0
8 of 8 declarations
